Upgrade StorageStyle Request: Journal of Clinical Oncology
Dear Adam,
I am seeking a style for the Journal of Clinical Oncology. The style instructions can be found here:
http://jco.ascopubs.org/site/ifc/prepguide.xhtml#Reference_Instructions
-------------------
A journal article with one, two, or three authors:
1. Dolan ME, Pegg AE: O6-Benzylguanine and its role in chemotherapy. Clin Cancer Res 8:837-847, 1997
Journal article with more than three authors:
2. Knox S, Hoppe RT, Maloney D, et al: Treatment of cutaneous T-cell lymphoma with chimeric anti-CD4 monoclonal antibody. Blood 87:893-899, 1996
Journal article in press (manuscript has been accepted for publication):
3. Scadden DT, Schenkein DP, Bernstein Z, et al: Combined immunotoxin and chemotherapy for AIDS-related non-Hodgkin's lymphoma. Cancer (in press)
Supplement:
4. Brusamolino E, Orlandi E, Morra E, et al: Analysis of long-term results and prognostic factors among 138 patients with advanced Hodgkin's disease treated with the alternating MOPP/ABVD chemotherapy. Ann Oncol 5:S53-S57, 1994 (suppl 2)
Book with a single author:
5. Woodruff R: Symptom Control in Advanced Cancer. Victoria, Australia, Asperula Pty Ltd, 1997, pp 65-69
Book with multiple authors:
6. Iverson C, Flanagin A, Fontanarosa PB, et al: American Medical Association Manual of Style (ed 9). Baltimore, MD, Williams & Wilkins, 1998
Chapter in a multiauthored book with editors:
7. Seykora JT, Elder DE: Common acquired nevi and dysplastic nevi as precursor lesions and risk markers of melanoma, in Kirkwood JM (ed): Molecular Diagnosis and Treatment of Melanoma. New York, NY, Marcel Dekker, 1998, pp 55-86
Abstract:
8. Bardia A, Wang AH, Hartmann LC, et al: Physical activity and risk of postmenopausal breast cancer defined by hormone receptor status and histology: A large prospective cohort study with 18 years of follow up. J Clin Oncol 24:49s, 2006 (suppl; abstr 1002)
9. Kaplan EH, Jones CM, Berger MS: A phase II, open-label, multicenter study of GW572016 in patients with trastuzumab refractory metastatic breast cancer. Proc Am Soc Clin Oncol 22:245, 2003 (abstr 981)
Conference/meeting presentation:
10. Dupont E, Riviere M, Latreille J, et al: Neovastat: An inhibitor of angiogenesis with anti-cancer activity. Presented at the American Association of Cancer Research Special Conference on Angiogenesis and Cancer, Orlando, FL, January 24-28, 1998
Internet resource:
11. Health Care Financing Administration: Bureau of data management and strategy from the 100% MEDPAR inpatient hospital fiscal year 1994: All inpatients by diagnosis related groups, 6/95 update. http://www.hcfa.gov/a1194drg.txt
Digital Object Identifier (DOI):
12. Small EJ, Smith MR, Seaman JJ, et al: Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer. J Clin Oncol 10.1200/JCO.2003.05.147
Government Announcement/Publication:
13. Miller BA, Ries CAG, Hankey BF, et al (eds): Cancer Statistics Review: 1973-1989. Bethesda, MD, National Cancer Institute, NIH publication No. 92-2789, 1992
ASCO Educational Book:
14. Benson AB III: Present and future role of prognostic and predictive markers for patients with colorectal cancer. Am Soc Clin Oncol Ed Book 187-190, 2006
-----------------------
The closest style that I can find is "Journal of Neuropsychiatry and Clinical Neurosciences".
Here are the differences I can find:
-There should be no period after et al ("et al:" not "et al.:")
-There should be no periods in journal abbreviations
-The date should follow a comma after the page numbers
-The reference number should be bold
-Only the first line of each reference should be indented.
-In text citations should be superscript
Thanks for your hard work.
-Mark
I am seeking a style for the Journal of Clinical Oncology. The style instructions can be found here:
http://jco.ascopubs.org/site/ifc/prepguide.xhtml#Reference_Instructions
-------------------
A journal article with one, two, or three authors:
1. Dolan ME, Pegg AE: O6-Benzylguanine and its role in chemotherapy. Clin Cancer Res 8:837-847, 1997
Journal article with more than three authors:
2. Knox S, Hoppe RT, Maloney D, et al: Treatment of cutaneous T-cell lymphoma with chimeric anti-CD4 monoclonal antibody. Blood 87:893-899, 1996
Journal article in press (manuscript has been accepted for publication):
3. Scadden DT, Schenkein DP, Bernstein Z, et al: Combined immunotoxin and chemotherapy for AIDS-related non-Hodgkin's lymphoma. Cancer (in press)
Supplement:
4. Brusamolino E, Orlandi E, Morra E, et al: Analysis of long-term results and prognostic factors among 138 patients with advanced Hodgkin's disease treated with the alternating MOPP/ABVD chemotherapy. Ann Oncol 5:S53-S57, 1994 (suppl 2)
Book with a single author:
5. Woodruff R: Symptom Control in Advanced Cancer. Victoria, Australia, Asperula Pty Ltd, 1997, pp 65-69
Book with multiple authors:
6. Iverson C, Flanagin A, Fontanarosa PB, et al: American Medical Association Manual of Style (ed 9). Baltimore, MD, Williams & Wilkins, 1998
Chapter in a multiauthored book with editors:
7. Seykora JT, Elder DE: Common acquired nevi and dysplastic nevi as precursor lesions and risk markers of melanoma, in Kirkwood JM (ed): Molecular Diagnosis and Treatment of Melanoma. New York, NY, Marcel Dekker, 1998, pp 55-86
Abstract:
8. Bardia A, Wang AH, Hartmann LC, et al: Physical activity and risk of postmenopausal breast cancer defined by hormone receptor status and histology: A large prospective cohort study with 18 years of follow up. J Clin Oncol 24:49s, 2006 (suppl; abstr 1002)
9. Kaplan EH, Jones CM, Berger MS: A phase II, open-label, multicenter study of GW572016 in patients with trastuzumab refractory metastatic breast cancer. Proc Am Soc Clin Oncol 22:245, 2003 (abstr 981)
Conference/meeting presentation:
10. Dupont E, Riviere M, Latreille J, et al: Neovastat: An inhibitor of angiogenesis with anti-cancer activity. Presented at the American Association of Cancer Research Special Conference on Angiogenesis and Cancer, Orlando, FL, January 24-28, 1998
Internet resource:
11. Health Care Financing Administration: Bureau of data management and strategy from the 100% MEDPAR inpatient hospital fiscal year 1994: All inpatients by diagnosis related groups, 6/95 update. http://www.hcfa.gov/a1194drg.txt
Digital Object Identifier (DOI):
12. Small EJ, Smith MR, Seaman JJ, et al: Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer. J Clin Oncol 10.1200/JCO.2003.05.147
Government Announcement/Publication:
13. Miller BA, Ries CAG, Hankey BF, et al (eds): Cancer Statistics Review: 1973-1989. Bethesda, MD, National Cancer Institute, NIH publication No. 92-2789, 1992
ASCO Educational Book:
14. Benson AB III: Present and future role of prognostic and predictive markers for patients with colorectal cancer. Am Soc Clin Oncol Ed Book 187-190, 2006
-----------------------
The closest style that I can find is "Journal of Neuropsychiatry and Clinical Neurosciences".
Here are the differences I can find:
-There should be no period after et al ("et al:" not "et al.:")
-There should be no periods in journal abbreviations
-The date should follow a comma after the page numbers
-The reference number should be bold
-Only the first line of each reference should be indented.
-In text citations should be superscript
Thanks for your hard work.
-Mark
https://gist.github.com/raw/1236907/1ca142f3620f3c09de5ff5be64336a0a34a03d20/journal-of-clinical-oncology.csl
drag the file to Firefox to install (or use the cite tab in the preferences for standalone).
Please report back - I haven't tested this much.
Also I don't understand these two:
-The reference number should be bold (which number? where?)
-Only the first line of each reference should be indented.
do you actually mean the first line should be indented? Or rather that the rest of the citation should be (as is common).
1 - Multiple citations should be condensed (currently reads 1 2 3 4 5 6, should read 1-6)
2 - In bibliography, the number preceding the reference should be bold.
3 - The bibliography indentation should be like a paragraph (first line indented, following lines not).
Here is a screenshot http://i.imgur.com/vyUWJ.png
Thanks for your hard work and quick responses.
-Mark
2. I fixed, new version here:
https://gist.github.com/raw/1236907/13ad37cf979b5c62ea36bd580907302f00985054/journal-of-clinical-oncology.csl
3. Isn't possible in Zotero - I removed the formatting that put the numbers outside of the citations, now it should be easy enough to adjust the for the bibliography in Word/Ooo (if you do that by changing the style "bibliography" it should stick even when Zotero updates the bibliography, these instructions apply: http://www.zotero.org/support/kb/word_default_font
A few things.
1 - The number still isn't coming up bold
2 - The style name in zotero is now "Journal of Neuropsychiatry and clinical neurosciences"
Thanks for your help,
Mark
www.zotero.org/styles